Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma

被引：329

作者：

Atwood, Scott X. ^{[1
,2
]}

Sarin, Kavita Y. ^{[1
,2
]}

Whitson, Ramon J. ^{[1
,2
]}

Li, Jiang R. ^{[1
,2
]}

Kim, Geurim ^{[1
,2
]}

Rezaee, Melika ^{[1
,2
]}

Ally, Mina S. ^{[1
,2
]}

Kim, Jinah ^{[1
,2
]}

Yao, Catherine ^{[1
,2
]}

Chang, Anne Lynn S. ^{[1
,2
]}

Oro, Anthony E. ^{[1
,2
]}

Tang, Jean Y. ^{[1
,2
]}

机构：

[1] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA

来源：

CANCER CELL | 2015年 / 27卷 / 03期

关键词：

HEDGEHOG PATHWAY INHIBITION; SOMATIC MUTATIONS; MEDULLOBLASTOMA; ACTIVATION; VISMODEGIB; CANCER; RECURRENT; GROWTH;

D O I：

10.1016/j.ccell.2015.02.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms. Here we identify SMO mutations in 50% (22 of 44) of resistant BCCs and show that these mutations maintain Hedgehog signaling in the presence of SMO inhibitors. Alterations include four ligand binding pocket mutations defining sites of inhibitor binding and four variants conferring constitutive activity and inhibitor resistance, illuminating pivotal residues that ensure receptor autoinhibition. In the presence of a SMO inhibitor, tumor cells containing either class of SMO mutants effectively outcompete cells containing the wild-type SMO. Finally, we show that both classes of SMO variants respond to aPKC-i/lambda or GLI2 inhibitors that operate downstream of SMO, setting the stage for the clinical use of GLI antagonists.

引用

收藏

页码：342 / 353

页数：12

相关论文

共 27 条

[1] Unraveling the therapeutic potential of the Hedgehog pathway in cancer [J].

Amakye, Dereck ;

Jagani, Zainab ;

Dorsch, Marion .

NATURE MEDICINE, 2013, 19 (11) :1410-1422

[2] GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas [J].

Atwood, Scott X. ;

Li, Mischa ;

Lee, Alex ;

Tang, Jean Y. ;

Oro, Anthony E. .

NATURE, 2013, 494 (7438) :484-488

[3] Hedgehog pathway inhibition and the race against tumor evolution [J].

Atwood, Scott X. ;

Chang, Anne Lynn S. ;

Oro, Anthony E. .

JOURNAL OF CELL BIOLOGY, 2012, 199 (02) :193-197

[4] U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma [J].

Axelson, Michael ;

Liu, Ke ;

Jiang, Xiaoping ;

He, Kun ;

Wang, Jian ;

Zhao, Hong ;

Kufrin, Dubravka ;

Palmby, Todd ;

Dong, Zedong ;

Russell, Anne Marie ;

Miksinski, Sarah ;

Keegan, Patricia ;

Pazdur, Richard .

CLINICAL CANCER RESEARCH, 2013, 19 (09) :2289-2293

[5] Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling [J].

Ayers, Katie L. ;

Therond, Pascal P. .

TRENDS IN CELL BIOLOGY, 2010, 20 (05) :287-298

[6] Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma [J].

Buonamici, Silvia ;

Williams, Juliet ;

Morrissey, Michael ;

Wang, Anlai ;

Guo, Ribo ;

Vattay, Anthony ;

Hsiao, Kathy ;

Yuan, Jing ;

Green, John ;

Ospina, Beatriz ;

Yu, Qunyan ;

Ostrom, Lance ;

Fordjour, Paul ;

Anderson, Dustin L. ;

Monahan, John E. ;

Kelleher, Joseph F. ;

Peukert, Stefan ;

Pan, Shifeng ;

Wu, Xu ;

Maira, Sauveur-Michel ;

Garcia-Echeverria, Carlos ;

Briggs, Kimberly J. ;

Watkins, D. Neil ;

Yao, Yung-mae ;

Lengauer, Christoph ;

Warmuth, Markus ;

Sellers, William R. ;

Dorsch, Marion .

SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (51)

[7] Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma [J].

Chang, Anne Lynn S. ;

Oro, Anthony E. .

ARCHIVES OF DERMATOLOGY, 2012, 148 (11) :1324-1325

[8] A Distinct Smoothened Mutation Causes Severe Cerebellar Developmental Defects and Medulloblastoma in a Novel Transgenic Mouse Model [J].

Dey, Joyoti ;

Ditzler, Sally ;

Knoblaugh, Sue E. ;

Hatton, Beryl A. ;

Schelter, Janell M. ;

Cleary, Michele A. ;

Mecham, Brig ;

Rorke-Adams, Lucy B. ;

Olson, James M. .

MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (20) :4104-4115

[9] Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance [J].

Dijkgraaf, Gerrit J. P. ;

Alicke, Bruno ;

Weinmann, Lasse ;

Januario, Thomas ;

West, Kristina ;

Modrusan, Zora ;

Burdick, Dan ;

Goldsmith, Richard ;

Robarge, Kirk ;

Sutherlin, Dan ;

Scales, Suzie J. ;

Gould, Stephen E. ;

Yauch, Robert L. ;

de Sauvage, Frederic J. .

CANCER RESEARCH, 2011, 71 (02) :435-444

[10] COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer [J].

Forbes, Simon A. ;

Bindal, Nidhi ;

Bamford, Sally ;

Cole, Charlotte ;

Kok, Chai Yin ;

Beare, David ;

Jia, Mingming ;

Shepherd, Rebecca ;

Leung, Kenric ;

Menzies, Andrew ;

Teague, Jon W. ;

Campbell, Peter J. ;

Stratton, Michael R. ;

Futreal, P. Andrew .

NUCLEIC ACIDS RESEARCH, 2011, 39 :D945-D950